Citizens Financial Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-918
Closed -$163K 1247
2020
Q1
$163K Buy
918
+324
+55% +$61K 0.01% 283
2019
Q4
$114K Buy
594
+307
+107% +$55.4K 0.01% 315
2019
Q3
$49K Buy
287
+224
+356% +$36.5K ﹤0.01% 369
2019
Q2
$11K Sell
63
-32
-34% -$4.43K ﹤0.01% 543
2019
Q1
$14K Buy
+95
New +$13.8K ﹤0.01% 474
2017
Q4
Sell
-368
Closed -$75K 537
2017
Q3
$75K Sell
368
-490
-57% -$114K 0.01% 304
2017
Q2
$209K Buy
858
+34
+4% +$7.99K 0.02% 232
2017
Q1
$197K Buy
824
+234
+40% +$54.5K 0.02% 233
2016
Q4
$124K Sell
590
-11
-2% -$2.28K 0.01% 266
2016
Q3
$138K Buy
601
+344
+134% +$84.1K 0.01% 265
2016
Q2
$59K Hold
257
0.01% 348
2016
Q1
$69K Sell
257
-57
-18% -$16.3K 0.01% 338
2015
Q4
$98K Buy
+314
New +$93.5K 0.01% 304

Other funds holding AGN

Citizens Financial Group's AGN Position: Q2 2020 in Review

Citizens Financial Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 918 shares — an estimated $163K sold.

Citizens Financial Group first reported a position in AGN in Q4 2015 and held it in 13 quarters. The position peaked at $209K in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Citizens Financial Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Citizens Financial Group sold 918 Allergan plc shares in Q2 2020, an estimated $163K.
  • Citizens Financial Group first reported a position in Allergan plc in Q4 2015 and held it in 13 quarters.
  • Citizens Financial Group's Allergan plc position peaked at $209K in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Citizens Financial Group's 13F filing for Q2 2020, filed 12 Aug 2020.